Investors Snag FULC 10.2% Cheaper Than Its Secondary Stock Offering
August 17, 2022 at 10:42 AM EDT
Looking back to 2 days ago, Fulcrum Therapeutics Inc (FULC) priced a 9,590,792 share secondary stock offering at $7.82 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
